แบบแสดงรายการข้อมูลสำหรับการเสนอขายหลักทรัพย์ (แบบ 69-1) 1 No. WHAUP-CS002/2562 February 22, 2019 Attention: Managing Director – Stock Exchange of Thailand Subject: Report of Financial Results for

subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 December 2019 MANAGEMENT DISCUSSION

ratio of 3:1. The exercising right is 1 warrant to 1 ordinary share. Due to the level of volatility in the market, the company will inform of the price prior to April 30, 2020 through the Stock Exchange

% Number of share in Rajthanee- Rojana Hospital % 1 Wudhikulprapan Group Mr. Wachira Wudhikulprapan Chairman of Executive Committee, Managing Director 7,453,249 2.48% 500,000 1.85% Mrs. Saranya Petchtong Mr

Microsoft Word - UPF61MD&A-E.doc ( Translation ) 25th February 2019 Subject: Management Discussion and Analysis (MD&A) for the year ends on 31st December 2018 To: Managing Director of the Stock

cash dividend payment at Baht 0.9 per share for 1,185,193,444 shares outstanding, total amount to be paid out (paid out from net profits after deduction of twice amount of some expenses: this makes the

2018 was in the same direction with the fact that the company was still managing the cost of goods sold efficiently. In this regard, the cost of sales increased from the expenses of domestic sales

subsidiary, please kindly find the following attachment. Please kindly be informed accordingly. Yours faithfully, Mr. Geza Emil Perlaki Managing Director For period ended 31 March 2020 MANAGEMENT DISCUSSION

million, because the Company had order to be used for the production of raw material to customers increased. - Investment in associated company decreased for 29.57 million Baht, because share of profit of

%) (31.79%) Tax income (expense) (2.64 ) 0.00 2.64 N/A (3.91%) 0.00% Profit (loss) for the period (23.21 ) (28.30 ) 5.09 17.99% (34.40%) (50.12%) Basic earnings per share-Owners of the Company (0.03 ) (0.03